comprehensive
Previous article:
Moonlake's readout produced a cash windfall. Risks remain
Next article: FDA has safety concerns on CRISPR
Next article: FDA has safety concerns on CRISPR
knowledge
hotspot
-
Meta's Zuckerberg and Chan on track to put $50 billion into science
2025-09-14 14:42 -
Researchers use wearables data and AI to predict preterm birth risk
2025-09-14 14:38 -
An exit interview with Bristol Myers Squibb CEO Giovanni Caforio
2025-09-14 14:29 -
FDA advisers vote against ALS treatment from BrainStorm
2025-09-14 13:00 -
Would Medicare drug price negotiations stall in a shutdown?
2025-09-14 12:11 -
CDC recommends rationing of RSV shot due to shortages
2025-09-14 12:09